Antibody-associated epilepsies: clinical features, evidence for immunotherapies and future research questions

<h4>Objectives</h4> <p>The growing recognition of epilepsies and encephalopathies associated with autoantibodies against surface neuronal proteins (LGI1, NMDAR, CASPR2, GABABR, and AMPAR) means that epileptologists are increasingly asking questions about mechanisms of antibody-medi...

詳細記述

書誌詳細
主要な著者: Irani, S, Reuber, M, Bakpa, O
フォーマット: Journal article
出版事項: Elsevier 2016